Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Sandler

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Prostate Cancer and Prostatic Diseases|February 23, 2024
Variation in communication of side effects in prostate cancer treatment consultationsTimothy J Daskivich, Aurash Naser-Tavakolian, Rebecca Gale, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentZachary A Seymour, Stephanie Daignault-Newton, P W McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?Jun Gong, Daniel M Kim, Amanda M De Hoedt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05Steven J Feigenberg, W Robert Lee, Michelle L Desilvio, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Nonlocal Means Denoising of Self-Gated and k-Space Sorted 4-Dimensional Magnetic Resonance Imaging Using Block-Matching and 3-Dimensional Filtering: Implications for Pancreatic Tumor Registration and SegmentationJun Jin, Elizabeth McKenzie, Zhaoyang Fan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2011
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trialsDaniel A Hamstra, Kyounghwa Bae, Miljenko V Pilepich, et al.
The Journal of Urology|April 4, 2022
Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment ConsultationsTimothy J Daskivich, Rebecca Gale, Michael Luu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Daily prostate targeting using implanted radiopaque markersDale Litzenberg, Laura A Dawson, Howard Sandler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology GroupArnab Chakravarti, Kathryn Winter, Chin-Lee Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2007
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trialMack Roach, Michelle De Silvio, Timothy Rebbick, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Prostate Cancer and Prostatic Diseases|February 23, 2024
Variation in communication of side effects in prostate cancer treatment consultationsTimothy J Daskivich, Aurash Naser-Tavakolian, Rebecca Gale, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentZachary A Seymour, Stephanie Daignault-Newton, P W McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?Jun Gong, Daniel M Kim, Amanda M De Hoedt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05Steven J Feigenberg, W Robert Lee, Michelle L Desilvio, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Nonlocal Means Denoising of Self-Gated and k-Space Sorted 4-Dimensional Magnetic Resonance Imaging Using Block-Matching and 3-Dimensional Filtering: Implications for Pancreatic Tumor Registration and SegmentationJun Jin, Elizabeth McKenzie, Zhaoyang Fan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2011
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trialsDaniel A Hamstra, Kyounghwa Bae, Miljenko V Pilepich, et al.
The Journal of Urology|April 4, 2022
Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment ConsultationsTimothy J Daskivich, Rebecca Gale, Michael Luu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Daily prostate targeting using implanted radiopaque markersDale Litzenberg, Laura A Dawson, Howard Sandler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology GroupArnab Chakravarti, Kathryn Winter, Chin-Lee Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2007
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trialMack Roach, Michelle De Silvio, Timothy Rebbick, et al.
Pageof 12